Cambridge Investment Research Advisors
RGEN icon

Cambridge Investment Research Advisors’s Repligen RGEN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,681
Closed -$242K – 3609
2024
Q4 		$242K Sell
1,681
-290
-15% -$41.6K ﹤0.01% 3027
2024
Q3 		$293K Sell
1,971
-144
-7% -$20.6K ﹤0.01% 2851
2024
Q2 		$267K Sell
2,115
-97
-4% -$15.2K ﹤0.01% 2799
2024
Q1 		$407K Buy
2,212
+127
+6% +$24.2K ﹤0.01% 2455
2023
Q4 		$375K Buy
2,085
+74
+4% +$11.5K ﹤0.01% 2429
2023
Q3 		$320K Buy
2,011
+1
+0% +$163 ﹤0.01% 2446
2023
Q2 		$284K Sell
2,010
-22
-1% -$3.53K ﹤0.01% 2572
2023
Q1 		$342K Sell
2,032
-38
-2% -$6.78K ﹤0.01% 2371
2022
Q4 		$350K Sell
2,070
-696
-25% -$126K ﹤0.01% 2308
2022
Q3 		$518K Sell
2,766
-372
-12% -$78.4K ﹤0.01% 1906
2022
Q2 		$510K Sell
3,138
-148
-5% -$23.4K ﹤0.01% 1948
2022
Q1 		$618K Sell
3,286
-2,194
-40% -$417K ﹤0.01% 1930
2021
Q4 		$1.45M Buy
5,480
+1,094
+25% +$295K 0.01% 1338
2021
Q3 		$1.27M Sell
4,386
-1,010
-19% -$259K 0.01% 1360
2021
Q2 		$1.08M Buy
5,396
+52
+1% +$10.1K 0.01% 1481
2021
Q1 		$1.04M Buy
5,344
+1,614
+43% +$331K 0.01% 1416
2020
Q4 		$715K Sell
3,730
-262
-7% -$47.7K ﹤0.01% 1533
2020
Q3 		$589K Buy
3,992
+1,054
+36% +$151K ﹤0.01% 1509
2020
Q2 		$363K Buy
+2,938
New +$346K ﹤0.01% 1741

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Cambridge Investment Research Advisors's RGEN Position: Q1 2025 in Review

Cambridge Investment Research Advisors sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,681 shares — an estimated $242K sold.

Cambridge Investment Research Advisors first reported a position in RGEN in Q2 2020 and held it in 19 quarters. The position peaked at $1.45M in Q4 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Cambridge Investment Research Advisors reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,681 Repligen shares in Q1 2025, an estimated $242K.
  • Cambridge Investment Research Advisors first reported a position in Repligen in Q2 2020 and held it in 19 quarters.
  • Cambridge Investment Research Advisors's Repligen position peaked at $1.45M in Q4 2021.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.